Van Den Eeckhout E, Belpaire F M, Bogaert M G, De Moerloose P
Eur J Drug Metab Pharmacokinet. 1980;5(1):45-8. doi: 10.1007/BF03189443.
In order to check the specificity of a radioimmunological assay for haloperidol and bromperidol reported by Michiels et al. (1) and commercialized by IRE (Fleurus, Belgium), the assay was performed on canine and human plasma samples with and without extraction. After a single dose of bromperidol in dogs, plasma levels obtained with and without extraction were similar. In man the plasma levels for bromperidol after a single administration were markedly lower after extraction. The same was true for haloperidol plasma levels after chronic dosing in man. The findings suggest that the direct radioimmunoassay of haloperidol or bromperidol with the commercialized kit, lacks specificity of humans, possibly because of the presence of one or more polar metabolites.
为检验Michiels等人(1)报道并由IRE公司(比利时弗勒吕斯)商业化生产的氟哌啶醇和溴哌利多放射免疫分析方法的特异性,该分析方法在有无萃取的犬类和人类血浆样本上进行。犬类单次服用溴哌利多后,有萃取和无萃取情况下获得的血浆水平相似。在人类中,单次给药后溴哌利多的血浆水平在萃取后显著降低。人类长期给药后氟哌啶醇的血浆水平情况也是如此。这些发现表明,使用商业化试剂盒对氟哌啶醇或溴哌利多进行直接放射免疫分析缺乏对人类的特异性,这可能是由于存在一种或多种极性代谢物。